42 CFR 460.190
§ 460.190 Monitoring during trial period.
United States · 42 CFR — Public Health · Status: effective
Cite this
- Citation
- 42 CFR 460.190, § 460.190 Monitoring during trial period, United States, version 1 as recorded 2026-07-09, yourstate.us, https://yourstate.us/provision/207016
- Permanent ID
ys:prov:207016@1- SHA-256
fa017fb74fbeaf76017a28bde9bd92b61c171c9625d52ba4ebb812f55099cfd6
The hash is SHA-256 of this version's text, with every run of whitespace collapsed to a single space and the ends trimmed. The ID always leads back here, and checking it says whether the text you cited is still the current version.
Full text
(a) Trial period review. During the trial period, CMS, in cooperation with the State administering agency, conducts comprehensive annual reviews of the operations of a PACE organization to ensure compliance with the requirements of this part.
(b) Scope of review. The review includes the following:
(1) An onsite visit to the PACE organization, which may include, but is not limited to, observation of program operations;
(2) Detailed analysis of the entity's substantial compliance with all significant requirements of sections 1894 and 1934 of the Act and this part, which may include review of marketing, participant services, enrollment and disenrollment, and grievances and appeals.
(3) A comprehensive assessment of an organization's fiscal soundness.
(4) A comprehensive assessment of the organization's capacity to furnish all PACE services to all participants.
(5) Any other elements that CMS or the State administering agency find necessary.
Legislative history
This is a federal regulation, adopted through agency rulemaking under the Administrative Procedure Act — not enacted by a recorded vote of Congress.